drugset / Trial / NCT01983722

Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome

NCT01983722 ↗

Expanded access Approved for marketing Children's Hospital Medical Center, Cincinnati

Summary

Expanded access to Stiripentol for patients with Dravet Syndrome.

Timeline

Start
—
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Stiripentol Small molecule — —

Indications